|
Stock-Based Compensation - Narrative (Details) (USD $)
|
12 Months Ended | 12 Months Ended | 3 Months Ended | 1 Months Ended | 1 Months Ended | 3 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | 12 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Sep. 30, 2013
|
Dec. 31, 2013
Vertro
|
Mar. 31, 2013
2005 LTIP and 2010 ECP Plan
|
Dec. 31, 2012
2005 LTIP
|
Feb. 29, 2012
Employee Compensation Plan 2010
|
Jan. 31, 2012
Employee Compensation Plan 2010
|
Dec. 31, 2012
Employee Compensation Plan 2010
|
Jul. 31, 2012
Restricted stock units
|
Dec. 31, 2013
Restricted stock units
|
Jun. 30, 2013
Restricted stock units
|
Mar. 31, 2013
Restricted stock units
|
Dec. 31, 2012
Restricted stock units
|
Jul. 31, 2012
Restricted stock units
Executive Officers, Senior Management and Board of Directors
|
Dec. 31, 2013
Restricted Stock
|
Dec. 31, 2012
Restricted Stock
|
Jul. 31, 2012
Restricted Stock
Management
|
Jul. 31, 2012
Restricted Stock
Non-management
|
Sep. 30, 2013
Restricted Stock Units- Service Based
|
Sep. 30, 2013
Restricted Stock Units- Performance Based
|
Dec. 31, 2013
Options
|
Dec. 31, 2012
Options
|
Dec. 31, 2013
Maximum
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||||||||||||||||
| Option and restricted stock unit vesting period | 3 years | 3 years | 3 years | |||||||||||||||||||||
| Compensation Expense | ||||||||||||||||||||||||
| Stock based compensation | $ 686,745 | $ 842,752 | $ 49,577 | |||||||||||||||||||||
| Compensation cost related to non vested awards not yet recognized | 701,164 | |||||||||||||||||||||||
| Average remaining expense recognition period | 1 year 3 months 18 days | |||||||||||||||||||||||
| Significant Grants and Cancellations | ||||||||||||||||||||||||
| Equity instruments other than options, grants in period (in shares) | 445,500 | 428,500 | 80,000 | 100,000 | 296,505 | 1,116,000 | 148,995 | 49,500 | 172,500 | 335,000 | ||||||||||||||
| Weighted average grant date price | $ 0.87 | $ 1.31 | $ 0.70 | |||||||||||||||||||||
| Shares settled | 252,755 | |||||||||||||||||||||||
| Shares issued | 173,371 | |||||||||||||||||||||||
| Options cancelled | 805,134 | |||||||||||||||||||||||
| Number of additional shares authorized (in shares) | 2,500,000.0 | 100,357 | ||||||||||||||||||||||
| Number of shares authorized (in shares) | 4,535,945 | 1,000,000.0 | 3,385,945 | |||||||||||||||||||||
| Equity instruments other than options, nonvested, weighted average grant date fair value (usd per share) | $ 1.45 | $ 0.71 | $ 0.56 | |||||||||||||||||||||
| Grants in period, weighted average grant date fair value | $ 1.44 | $ 0.77 | $ 0.72 | $ 1.07 | ||||||||||||||||||||
| Award Information and Activity | ||||||||||||||||||||||||
| Expected forfeiture rate | 4.60% | |||||||||||||||||||||||
| Aggregate intrinsic value of outstanding options | 0 | 0 | ||||||||||||||||||||||
| Weighted average remaining contractual term | 6 years 10 months 15 days | 1 year 1 month 1 day | ||||||||||||||||||||||
| Number of options exercisable (in shares) | 266,408 | |||||||||||||||||||||||
| Intrinsic value of options exercisable | 0 | |||||||||||||||||||||||
| Weighted average exercise price | $ 2.72 | |||||||||||||||||||||||
| Weighted average remaining contractual term | 6 years 11 months 15 days | |||||||||||||||||||||||
| Fair value of options vested | 240,000 | 609,000 | ||||||||||||||||||||||
| Intrinsic value of options exercised | 2,813 | |||||||||||||||||||||||
| Options forfeited and expired in period | 882,703 | 5,504 | ||||||||||||||||||||||
| Forfeited or expired, weighted average exercise price | $ 2.65 | $ 22.64 | ||||||||||||||||||||||
| Options outstanding | 292,746 | 1,179,199 | 165,827 | |||||||||||||||||||||
| Options, weighted average exercise price | $ 2.72 | $ 2.66 | $ 45.36 | $ 18.14 | $ 2.56 | |||||||||||||||||||
| Weighted average fair value of options | $ 0 | |||||||||||||||||||||||
| Range of exercise price, lower Llmit (usd per share) | $ 12.55 | |||||||||||||||||||||||
| Range of exercise price, upper limit (usd per share) | $ 74.84 | |||||||||||||||||||||||
| Granted in period | 0 | 49,500 | ||||||||||||||||||||||
| Forfeited in period | 0 | |||||||||||||||||||||||